Belluscura (BELL)

Sector:

Health Care

Index:

FTSE AIM All-Share

1.00p
   
  • Change Today:
    -0.14p
  • 52 Week High: 17.25
  • 52 Week Low: 0.55
  • Currency: UK Pounds
  • Shares Issued: 401.31m
  • Volume: 8,694,035
  • Market Cap: £4.01m

Belluscura Overview

Belluscura focuses on novel oxygen-based treatment platforms that can be adapted and applied in a wide range of markets beyond those traditionally applicable to a single product or product line. Its range of portable products will be lighter / more adaptable / have higher O₂ capacity than existing oxygen enrichment products. Whilst potentially useful for recovering COVID patients, it has a wide range of use for sufferers of pneumonia / COPD (i.e. asthma/ emphysema /chronic bronchitis) and other respiratory illnesses.

1 Day Chart (15-05-2025)

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -2144.5% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 6.5 n/a
Pr/Book 0.3  
Latest F'cast
Revenue -41.0% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Belluscura Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (1.98) (0.04)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 0.42 (5.21) (5.50)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 1.40 (8.15) (5.50)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 0.82 (18.52) (14.20)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Belluscura Company Announcements

Response to Share Price Movement 13-May-2025 12:54 RNS
Trading update & commencement of strategic review 09-May-2025 07:00 RNS
Trading Update and Directorate Change 16-Apr-2025 07:00 RNS

Latest Belluscura Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Belluscura Market Data

Currency UK Pounds
Share Price 1.00p
Change Today -0.14p
% Change -12.28 %
52 Week High 17.25
52 Week Low 0.55
Volume 8,694,035
Shares Issued 401.31m
Market Cap £4.01m

Belluscura Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
73.81% above the market average73.81% above the market average73.81% above the market average73.81% above the market average73.81% above the market average
94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average94.12% above the sector average
Price Trend
99.5% below the market average99.5% below the market average99.5% below the market average99.5% below the market average99.5% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Income Not Available
Growth
2.74% below the market average2.74% below the market average2.74% below the market average2.74% below the market average2.74% below the market average
2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average

Belluscura Dividends

No dividends found

Trades for 15-May-2025

Time Volume / Share Price
15:49 100 @ 0.98p
15:10 104,448 @ 1.05p
15:05 47,374 @ 1.05p
15:04 100,000 @ 0.96p
15:00 288,444 @ 1.04p

Belluscura Key Personnel

CEO Robert “Bob” Rauker

Top of Page